Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-07T01:07:37.556Z Has data issue: false hasContentIssue false

Multimodality cardiac imaging in Turner syndrome

Published online by Cambridge University Press:  04 February 2016

Kristian H. Mortensen*
Affiliation:
Department of Radiology, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Deepa Gopalan
Affiliation:
Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Bjarne L. Nørgaard
Affiliation:
Department of Cardiology, Aarhus University Hospital, Aarhus University Hospital, Aarhus, Denmark
Niels H. Andersen
Affiliation:
Department of Cardiology, Aarhus University Hospital, Aarhus University Hospital, Aarhus, Denmark
Claus H. Gravholt
Affiliation:
Department of Endocrinology and Internal Medicine & Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
*
Correspondence to: Dr K. H. Mortensen, PhD, Department of Radiology, School of Clinical Medicine, Cambridge University and Cambridge University Hospitals NHS Foundation Trust, Box 218, Hills Road, Cambridge CB2 0QQ, United Kingdom. Tel: +44 0 1223 336890; Fax: +44 0 1223 330915; E-mail: mortensen@doctors.org.uk
Rights & Permissions [Opens in a new window]

Abstract

Congenital and acquired cardiovascular diseases contribute significantly to the threefold elevated risk of premature death in Turner syndrome. A multitude of cardiovascular anomalies and disorders, many of which deleteriously impact morbidity and mortality, is frequently left undetected and untreated because of poor adherence to screening programmes and complex clinical presentations. Imaging is essential for timely and effective primary and secondary disease prophylaxis that may alleviate the severe impact of cardiovascular disease in Turner syndrome. This review illustrates how cardiovascular disease in Turner syndrome manifests in a complex manner that ranges in severity from incidental findings to potentially fatal anomalies. Recommendations regarding the use of imaging for screening and surveillance of cardiovascular disease in Turner syndrome are made, emphasising the key role of non-invasive and invasive cardiovascular imaging to the management of all patients with Turner syndrome.

Information

Type
Review Articles
Copyright
© Cambridge University Press 2016 
Figure 0

Figure 1 Timely detection of congenital cardiovascular anomalies in Turner syndrome requires systematic imaging in all patients and early targeted imaging when symptoms are present. A 17-year-old (a) has an occult aortic coarctation (a, arrow) and bicuspid aortic valve (a, inset), and a 55-year-old (b) has an “elongated transverse aortic arch” (b, arrow) and mild regurgitation of a bicuspid aortic valve (b, inset). A 44-year-old (c) incidentally has aberrant origins of left and right common carotid arteries (LCA, RCA) from a common arterial trunk and a retro-oesophageal right subclavian artery (RSA) that arises distal to the left subclavian artery (LSA). A 16-year-old (d–g) with Shone complex, comprised of aortic coarctation corrected surgically in infancy with no residual coarctation (d), a false tendon of the left ventricle (e, arrow), subaortic obstruction (f, arrow), and a supramitral ring (g, arrow) above a parachute mitral valve. TTE=transthoracic echocardiography.

Figure 1

Table 1 Cardiovascular abnormalities in Turner syndrome and their clinical significance.

Figure 2

Table 2 Sensitivity of non-invasive imaging for the detection of cardiovascular disease in Turner syndrome, and suggested screening strategy for patients without concerning cardiac symptoms or urgent treatment-requiring anomaly.

Figure 3

Figure 2 Bicuspid aortic valves, native or surgically replaced, render patients with Turner syndrome especially prone to aortic, valvular, and cardiomyopathic complications, but imaging surveillance is warranted irrespective of valve morphology because of an increased risk of complications also seen with tricuspid aortic valves. A 21-year-old (a) with valve replacement for a stenotic bicuspid aortic valve (a, arrowhead) has biventricular cardiomyopathy with severe tricuspid regurgitation (a, circle), right atrial (RA) and right ventricular (RV) dilatation, and smooth interlobular septal thickening consistent with pulmonary venous congestion (a, black arrow). A 30-year-old (b) with a severely stenotic tricuspid aortic valve (b, large arrows {aortic valve} and star {stenotic jet}) and concentric left ventricular (LV) hypertrophy (b, asterisks) with preserved global systolic function with systolic mid and apical chamber obliteration (b, circle), and patchy delayed enhancement in the subendocardial apical and mid-septal myocardium (b, small arrows). An 18-year-old (c) with valvotomy for pulmonic stenosis has minimal flow acceleration (c, arrow) across a trivially regurgitant valve, mild main pulmonary artery dilatation (b, asterisk), and mild free-wall hypertrophy (6 mm) of the non-dilated RV (c, arrowheads). CXR=chest X-ray; TOE=transoesophageal echocardiography; TTE=transthoracic echocardiography.

Figure 4

Figure 3 Aortic aneurysm is common in Turner syndrome and warrants imaging surveillance during the entire lifetime, which applies irrespective of cardiovascular phenotype, although some guidance can be taken by the presence of risk factors such as bicuspid aortic valves, elevated blood pressure, and aortic diameter. A 15-year-old (a), with childhood commissurotomy for a congenitally stenotic bicuspid aortic valve, has a 4.5-cm (2.7 cm/m2) ascending aorta (a, asterisk) with a bovine arch (a, star). A 50-year-old (b), with bicuspid aortic valve (normal function) and childhood end-to-end aortic coarctation repair, has a 5.0-cm (4.0 cm/m2) ascending aorta also with a bovine arch (b, star) that is hypoplastic hypoplasia (b, arrow). A 69-year-old (c), with mechanical aortic valve prosthesis (11 years before for a stenotic bicuspid aortic valve), had a 5.0-cm (4.0 cm/m2) ascending aorta (c, asterisk) and extensive atherosclerosis of the major thoracic and abdominal arteries (c, arrows). A 57-year-old (d) with severe stenosis of a thickened tricuspid aortic valve (a, circles) and severe ascending aortic dilatation (d, black arrow and stars) with a normally functioning aortic valve prosthesis and interposition graft in situ 12 months later (d, white arrows and square box). CXR=chest X-ray; TTE = transeosophageal echocardiography.

Figure 5

Figure 4 A low threshold for excluding aortic dissection should be adapted in Turner syndrome, and when reviewing imaging it is important to scrutinise for additional anomalies. A 44-year-old with acute Stanford type A dissection (asterisk [false lumen], star [true lumen], circle [entry point]) occurring years after mechanical aortic valve replacement (arrow) due to a stenotic bicuspid aortic valve. Note is made of an incidental, haemodynamically non-significant partial anomalous pulmonary venous return consisting of middle and right upper lobar pulmonary veins draining to the superior caval vein (arrowhead).

Figure 6

Figure 5 Treatment of aortic anomalies in Turner syndrome does not abolish the need for continued imaging follow-up due to a high risk of recurrent coarctation and aortic aneurysm formation. A 17-year-old (a) has mild narrowing at a subclavian flap repair site (a, arrows) with normal flow and only mild post-isthmic dilatation (a, stars). A 35-year old (b) demonstrates re-coarctation (b, arrow) of an end-to-end coarctation repair, and a 63-year-old (c) has severe narrowing (6 mm) of a subclavian flap coarctation repair (c, arrows) with severe post-stenotic dilatation (c, asterisk) and left ventricular (LV) hypertrophy (c, star). A 47-year-old (d) has a patent 10 mm graft bypassing a hypoplastic transverse arch (d, circle) with severe ascending and descending aortic dilatation. TTE=transthoracic echocardiography.

Figure 7

Figure 6 The high prevalence of partial anomalous pulmonary venous return warrants screening early in life in Turner syndrome, although the shunt size often does not warrant surgical correction. A 26-year-old (a) has a haemodynamically significant partial anomalous pulmonary venous return, evident as right atrial (RA) and ventricular (RV) enlargement with pulmonary plethora (a, circle) that result from anomalous middle and bilateral upper pulmonary veins (a, arrows) that drain into a dilated superior caval vein (SVC) and innominate vein (INV). Incidentally, there is mild narrowing of the descending aorta, with a posterior shelf and an aneurysmal left subclavian artery (a, square). A 51-year-old (b) with scimitar-type anomalous pulmonary venous drainage developed pulmonary vein thrombosis after surgical re-direction of right-sided pulmonary veins to the left atrium, which necessitated pneumonectomy for unilateral pulmonary hypertension with subsequent extreme cardiac dextroposition but normal cardiac function and volumes. CXR=chest X-ray; TTE=transthoracic echocardiography.

Figure 8

Figure 7 Congenital and acquired coronary artery anomalies in Turner syndrome should always be considered at baseline cardiovascular imaging with targeted coronary imaging warranted when congenital anomalies are suspected, in symptomatic patients, and before major cardiothoracic surgery. In a 27-year-old (a), a coronary artery was noted (a, circle) in the left atrioventricular groove with the origin not seen but later confirmed to be a left circumflex coronary artery (LCX) with aberrant origin from the proximal right coronary artery (RCA) and a course between the left atrium (LA) and the aorta towards the left atrioventricular groove. A normal left anterior descending artery (LAD) was noted. In a 34-year-old (b), impaired left ventricular function (not shown) led to the diagnosis of a moderate atherosclerotic stenosis of the proximal LAD (b, arrow). In a 61-year-old (c), with previous coronary artery bypass operation and implanted cardioverter defibrillator, an incidental persistent left superior caval vein was evident from an anomalous course of the pacemaker leads (c, arrow). CCT=cardiac CT; TTE=transthoracic echocardiography; CAG = coronary angiography.